Adimab, Inc. Lands Series B Financing Round

  • Feed Type
  • Date
    3/25/2008
  • Company Name
    Adimab, Inc.
  • Mailing Address
    16 Cavendish Court Lebanon, NH 03766
  • Company Description
    Adimab–which stands for Antibody Discovery Maturation Biomanufacturing–is developing a platform that’s deliberately engineered to minimize and potentially eliminate third party royalties, offering a one-stop-service-shop to a select few Big Pharma partners.
  • Website
    http://www.adimab.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Series B
  • Proceeds Purposes
    “Since Adimab’s founding in 2007 we have experienced significant interest from both potential partners and investment groups,” said Errik Anderson, Vice President of Operations and Finance. “This financing, at a significant step up in valuation, allows us to confidently build the capacity to execute multiple programs with our partners.”
  • M&A Terms
  • Venture Investor
    Polaris Venture Partners
  • Venture Investor
    SV Life Sciences

By posting a comment, you agree to our terms and conditions.